• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Pakistan Pharmaceuticals and Healthcare Report Q1 2013 - Product Image

Pakistan Pharmaceuticals and Healthcare Report Q1 2013

  • Published: December 2012
  • Region: Pakistan
  • 98 pages
  • Business Monitor International

FEATURED COMPANIES

  • Abbott Laboratories
  • Ferozsons Laboratories
  • GlaxoSmithKline (GSK)
  • Local Manufacturers
  • Pacific Pharmaceuticals
  • Sanofi-Aventis
  • MORE

BMI View: For new medicines to be launched into the Pakistani market, the pharmaceutical regulator must drop its requirement for local rigorous drug approvals and registration process. The country does not have the necessary number of trained professionals to effectively monitor the costly and timely process, while patients would benefit from more rapidly introduced pharmaceuticals. Drugmakers would also see higher commercial upside if the requirements were withdrawn.

Headline Expenditure Projections:

- Pharmaceuticals: PKR171.20bn (US$1.98bn) in 2011 to PRK189.22bn (US2.05bn) in 2012;
+10.5% in local currency terms and +3.2% in US dollar terms.

- Healthcare: PKR361.13bn (US$4.18bn) in 2011 to PKR399.54bn (US$4.32bn) in 2012;
+10.5% in local currency terms and +6.9% in US dollar terms.

- Medical devices: PKR35.14bn (US$407mn) in 2011 to PKR40.48bn (US$438mn) in 2012;
+14.8% in local currency terms and +11.1% in US dollar terms.

Risk/Reward Ratings:

We continue to expect improving healthcare provision in Asia Pacific to bring opportunities for pharmaceutical and medical devices players due to a wider pool of patients. However,
the READ MORE >

Executive Summary 5

SWOT Analysis 7

Pakistan Pharmaceutical Industry SWOT 7

Pakistan Political SWOT 8

Pakistan Economic SWOT 9

Pakistan Business Environment SWOT 9

Pharmaceutical Risk/Reward Ratings 10
Table: Asia Pacific Pharmaceutical Risk/Reward Ratings, Q113 10

Rewards 11

Risks 11

Pakistan – Market Summary 12

Regulatory Regime 13

Regulatory Developments 14

Intellectual Property Regime 15

IP Shortcomings 16

Pricing Regime 17

Reimbursement Regime 18

Industry Trends And Developments 20

Epidemiology 20

Healthcare System 21
Table: Healthcare Facilities, 2001-2009 23
Table: Beds by Healthcare Facility, 2001-2009 24

Healthcare Insurance 24

Research And Development 25

Clinical Trials 26

Medical Devices 27

Industry Forecast Scenario 28

Pharmaceutical Market Forecast 28
Table: Pharmaceutical Sales Indicators 2008-2016 29

Healthcare Market Forecast 30
Table: Healthcare Expenditure Indicators 2008-2016 31
Table: Healthcare Governmental Indicators 2008-2016 31
Table: Healthcare Private Indicators 2008-2016 32

Key Growth Factors – Macroeconomic 33
Table: Economic Activity, 2008-2016 39

Prescription Drug Market Forecast 40
Table: Prescription Drug Sales Indicators 2008-2016 41

Patented Drug Market Forecast 42
Table: Patented Drug Market Indicators 2008-2016 43

Generic Drug Market Forecast 44
Table: Generic Drug Sales Indicators 2008-2016 45

OTC Medicine Market Forecast 46
Table: OTC Medicine Sales Indicators 2008-2016 47

Pharmaceutical Trade Forecast 48
Table: Exports and Imports Indicators 2008-2016 50

Medical Device Market Forecast 51
Table: Medical Devices Sales Indicators 2008-2016 51

Other Healthcare Data Forecasts 53

Key Risks To BMI's Forecast Scenario 54

Competitive Landscape 56

Pharmaceutical Sector 56

Barriers To Investment 56

Investment Opportunities 58
Table: 2008 Financial Snapshot Of Pakistani Drugmakers Listed On The Karachi Stock Exchange (US$mn) 58

Domestic Pharmaceutical Industry 59

Foreign Pharmaceutical Industry 62

Recent Pharmaceutical Sector Developments 63

Pharmaceutical Distribution Sector 64

Pharmaceutical Retail 64

Company Monitor 65

Local Manufacturers 65

Searle Pakistan 65

Hilton Pharma 67

Efroze Chemical Industries 69

Ferozsons Laboratories 71

Getz Pharma 73

Pacific Pharmaceuticals 75

Leading Multinational Manufacturers 77

GlaxoSmithKline (GSK) 77

Pfizer 80

Abbott Laboratories 82

Novartis 84

Sanofi-Aventis 86

Demographic Outlook 88

Pakistan – Population By Age Group 89

Pakistan – Population By Age Group 90

Pakistan – Key Population Ratios 91

Pakistan – Rural and Urban Population 91

Glossary 92

BMI Methodology 94

How We Generate Our Pharmaceutical Industry Forecasts 94

Pharmaceuticals Business Environment Ratings 95

Risk/Reward Ratings Methodology 95

Ratings Overview 95
Table: Pharmaceutical Business Environment Indicators 96

Weighting 97
Table: Weighting Of Components 97

Sources 97

Company Monitor
Local Manufacturers
Searle Pakistan
Hilton Pharma
Efroze Chemical Industries
Ferozsons Laboratories
Getz Pharma
Pacific Pharmaceuticals
Leading Multinational Manufacturers
GlaxoSmithKline (GSK)
Pfizer
Abbott Laboratories
Novartis
Sanofi-Aventis

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos